Acro Biomedical (ACBM) Times Interest Earned (2018 - 2025)
Acro Biomedical has reported Times Interest Earned over the past 8 years, most recently at -$42.47 for Q3 2025.
- Quarterly results put Times Interest Earned at -$42.47 for Q3 2025, down 423.79% from a year ago — trailing twelve months through Dec 2025 was -$25.56 (down 192.23% YoY), and the annual figure for FY2024 was -$8.75, up 98.48%.
- Times Interest Earned for Q3 2025 was -$42.47 at Acro Biomedical, down from -$6.99 in the prior quarter.
- Over the last five years, Times Interest Earned for ACBM hit a ceiling of $8268.6 in Q4 2023 and a floor of -$18940.4 in Q2 2022.
- Median Times Interest Earned over the past 5 years was -$580.34 (2021), compared with a mean of -$3781.4.
- Biggest five-year swings in Times Interest Earned: tumbled 82455.26% in 2022 and later skyrocketed 265.42% in 2023.
- Acro Biomedical's Times Interest Earned stood at -$705.05 in 2021, then tumbled by 608.97% to -$4998.6 in 2022, then skyrocketed by 265.42% to $8268.6 in 2023, then crashed by 100.1% to -$7.86 in 2024, then crashed by 440.54% to -$42.47 in 2025.
- The last three reported values for Times Interest Earned were -$42.47 (Q3 2025), -$6.99 (Q2 2025), and -$6.54 (Q1 2025) per Business Quant data.